Earnings Per Share [Text Block] |
NOTE 4 - EARNINGS PER COMMON SHARE
The following table presents the amounts used to compute basic and diluted earnings per common share, as well as the effect of dilutive potential common shares on weighted average shares outstanding (in thousands, except per share data):
| | Three Months Ended | | | Nine Months Ended | |
| | March 31 | | | March 31 | |
| | 2021 | | | 2020 | | | 2021 | | | 2020 | |
| | | | | | | | | | | | | | | | |
BASIC EARNINGS PER SHARE | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
Net income | | $ | 1,472 | | | $ | 1,861 | | | $ | 5,670 | | | $ | 8,079 | |
| | | | | | | | | | | | | | | | |
Weighted average shares outstanding during the period, net of treasury shares | | | 26,467 | | | | 26,151 | | | | 26,384 | | | | 26,087 | |
Weighted average vested restricted stock units outstanding | | | 20 | | | | 6 | | | | 16 | | | | 7 | |
Weighted average shares outstanding in the Deferred Compensation Plan during the period | | | 284 | | | | 144 | | | | 242 | | | | 156 | |
Weighted average shares outstanding | | | 26,771 | | | | 26,301 | | | | 26,642 | | | | 26,250 | |
| | | | | | | | | | | | | | | | |
Basic income per share | | $ | 0.05 | | | $ | 0.07 | | | $ | 0.21 | | | $ | 0.31 | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
DILUTED EARNINGS PER SHARE | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
Net income | | $ | 1,472 | | | $ | 1,861 | | | $ | 5,670 | | | $ | 8,079 | |
| | | | | | | | | | | | | | | | |
Weighted average shares outstanding: | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
Basic | | | 26,771 | | | | 26,301 | | | | 26,642 | | | | 26,250 | |
| | | | | | | | | | | | | | | | |
Effect of dilutive securities (a): | | | | | | | | | | | | | | | | |
Impact of common shares to be issued under stock option plans, and contingently issuable shares, if any | | | 956 | | | | 322 | | | | 710 | | | | 173 | |
Weighted average shares outstanding | | | 27,727 | | | | 26,623 | | | | 27,352 | | | | 26,423 | |
| | | | | | | | | | | | | | | | |
Diluted income per share | | $ | 0.05 | | | $ | 0.07 | | | $ | 0.21 | | | $ | 0.31 | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
Anti-dilutive securities (b) | | | 654 | | | | 1,875 | | | | 1,017 | | | | 2,038 | |
| (a) | Calculated using the “Treasury Stock” method as if dilutive securities were exercised and the funds were used to purchase common shares at the average market price during the period. |
| (b) | Anti-dilutive securities were excluded from the computation of diluted net income per share for the three and nine months ended March 31, 2021 and March 31, 2020 because the exercise price was greater than the average fair market price of the common shares or because the assumed proceeds from the award’s exercise or vesting was greater than the average fair market price of the common shares. |
|